LIVIVO - Search results -

Search results

Result 1 - 10 of total 42

Search options

Article: [Soil infiltration characteristics under main vegetation types in Anji County of Zhejiang Province].

Liu, Dao-Ping / Chen, San-Xiong / Zhang, Jin-Chi / Xie, Li / Jiang, Jiang

Ying yong sheng tai xue bao = The journal of applied ecology

2007 Volume 18, Issue 3, Page(s) 493–498

Abstract: The study on the soil infiltration under different main vegetation types in Anji County of Zhejiang ...

Abstract	The study on the soil infiltration under different main vegetation types in Anji County of Zhejiang Province showed that the characteristics of soil infiltration differed significantly with land use type, and the test eight vegetation types could be classified into four groups, based on soil infiltration capability. The first group, deciduous broadleaved forest, had the strongest soil infiltration capability, and the second group with a stronger soil infiltration capability was composed of grass, pine forest, shrub community and tea bush. Bamboo and evergreen broadleaved forest were classified into the third group with a relatively strong soil infiltration capability, while bare land belonged to the fourth group because of the bad soil structure and poorest soil infiltration capability. The comprehensive parameters of soil infiltration (alpha) and root (beta) were obtained by principal component analysis, and the regression model of alpha and beta could be described as alpha = 0. 1708ebeta -0. 3122. Soil infiltration capability was greatly affected by soil physical and chemical characteristics and root system. Fine roots (< or = 1 mm in diameter) played effective roles on the improvement of soil physical and chemical properties, and the increase of soil infiltration capability was closely related to the amount of the fine roots.
MeSH term(s)	Biodegradation, Environmental ; Pinus/growth & development ; Pinus/physiology ; Plant Roots/physiology ; Poaceae/growth & development ; Soil/analysis ; Tea/growth & development ; Trees/growth & development ; Trees/physiology ; Water Movements
Chemical Substances	Soil ; Tea
Language	Chinese
Publishing date	2007-03
Publishing country	China
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2881809-X
ISSN	1001-9332
ISSN	1001-9332
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Innovative use of telitacicept in Ehlers-Danlos syndrome.

Zhao, Yanzao / Chen, Jie / Xiong, Anji

Medicina clinica

2024 Volume 162, Issue 3, Page(s) 141–142

MeSH term(s)	Humans ; Ehlers-Danlos Syndrome/diagnosis ; Recombinant Fusion Proteins
Chemical Substances	telitacicept ; Recombinant Fusion Proteins
Language	Spanish
Publishing date	2024-01-11
Publishing country	Spain
Document type	Letter
ZDB-ID	411607-0
ISSN	1578-8989 ; 0025-7753
ISSN (online)	1578-8989
ISSN	0025-7753
DOI	10.1016/j.medcli.2023.06.043
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.279: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Response to "Do not ignore another risk factor of invasive fungal infections in patients with connective tissue disease".

Luo, Wenxuan / Tu, Huawei / Xiong, Anji

Seminars in arthritis and rheumatism

2024 Volume 65, Page(s) 152395

MeSH term(s)	Humans ; Risk Factors ; Invasive Fungal Infections/epidemiology ; Connective Tissue Diseases/complications
Language	English
Publishing date	2024-01-29
Publishing country	United States
Document type	Letter
ZDB-ID	120247-9
ISSN	1532-866X ; 0049-0172
ISSN (online)	1532-866X
ISSN	0049-0172
DOI	10.1016/j.semarthrit.2024.152395
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 790: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Cyclophosphamide in the Treatment of Systemic Lupus Erythematosus-related Guillain-Barré Syndrome: A Systematic Review of Case Reports.

Xiong, Anji / Cui, Hongxu / Deng, Ruiting / Wei, Xin

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

2023 Volume 18, Issue 3, Page(s) 285–293

Abstract: A small category of Guillain-Barré syndrome (GBS) occurs in the presence of systemic lupus erythematosus (SLE). However, specific treatments for this condition have not been established. Cyclophosphamide (CYC) has been reported to benefit patients with ... ...

Abstract	A small category of Guillain-Barré syndrome (GBS) occurs in the presence of systemic lupus erythematosus (SLE). However, specific treatments for this condition have not been established. Cyclophosphamide (CYC) has been reported to benefit patients with SLE-related GBS in some isolated case reports. Consequently, our objective was to investigate the effectiveness of CYC in SLE-related GBS by means of a systematic literature review. Three online databases, PubMed, Embase and Web of Science, were searched for English articles describing the effectiveness of CYC treatment for SLE-related GBS. We extracted data on patient characteristics, disease course, and CYC efficacy and tolerance. Of 995 studies identified, 26 were included in this systematic review. The data for 28 patients (9 men and 19 women) with SLE-related GBS were reviewed, and the patient age at diagnosis varied from 9 to 72 years (mean: 31.5 years [median: 30.5 years]). Sixteen patients (57.1%) had SLE-related GBS before SLE diagnosis. With regard to CYC response, 24 patients (85.7%) showed resolution (46.4%) or improvement (39.3%) of neurological symptoms. Relapse occurred in one patient (3.6%). Four patients (14.3%) showed no improvement in neurological symptoms following CYC administration. With regard to CYC safety, infections developed in two patients (7.1%), and one death (3.6%) due to posterior reversible encephalopathy syndrome was reported. Lymphopenia developed in one patient (3.6%). Our preliminary data suggest that CYC appears to be an effective treatment for SLE-related GBS. However, it is important to differentiate patients with pure GBS concurrent with SLE, because CYC is ineffective for pure GBS.
Language	English
Publishing date	2023-06-30
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	2227405-4
ISSN	1557-1904 ; 1557-1890
ISSN (online)	1557-1904
ISSN	1557-1890
DOI	10.1007/s11481-023-10075-w
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Details ▾
- Full text online
- Order with fees

Article ; Online: Combined glucocorticoids and cyclophosphamide in the treatment of Graves' ophthalmopathy: a systematic review and meta-analysis.

Xiang, Qilang / Yang, Mengling / Luo, Wenxuan / Cao, Yuzi / Shuai, Shiquan / Wei, Xin / Xiong, Anji

BMC endocrine disorders

2024 Volume 24, Issue 1, Page(s) 12

Abstract: Purpose: To evaluate the efficacy and safety of combined glucocorticoids (GCs) and cyclophosphamide (CYC) treatment in Graves' ophthalmopathy (GO).: Methods: We searched PubMed, Embase, Cochrane Library, and four Chinese databases (Chinese National ... ...

Abstract	Purpose: To evaluate the efficacy and safety of combined glucocorticoids (GCs) and cyclophosphamide (CYC) treatment in Graves' ophthalmopathy (GO). Methods: We searched PubMed, Embase, Cochrane Library, and four Chinese databases (Chinese National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), WanFang, and SinoMed) for any published randomized controlled trials (RCTs) produced from inception to December 1, 2023. Articles obtained using appropriate keywords were selected independently by two reviewers according to the established inclusion and exclusion criteria. Findings: We retrieved 1120 records which were eventually reduced to 13 RCTs which were then included in this evaluation. Pooled results indicated that the experimental group (CYC/GCs) showed a higher response rate than control group (GCs or negative control) (RR 1.27; 95% confidence interval 1.19 to 1.37). The subgroup analysis showed that the difference in response rates among treatment protocols (CYC/P, CYC/MPS, CYC/DEX) was not statistically significant (p = 0.23). Implications: The combination of GCs and CYC could be recommended as a therapeutic option for GO, especially in patients who experience recurrence after a withdrawal GCs, have a poor response to GCs, or cannot obtain monoclonal antibody agents for various reasons.
MeSH term(s)	Humans ; Glucocorticoids/therapeutic use ; Graves Ophthalmopathy/drug therapy ; Cyclophosphamide/therapeutic use ; China
Chemical Substances	Glucocorticoids ; Cyclophosphamide (8N3DW7272P)
Language	English
Publishing date	2024-01-26
Publishing country	England
Document type	Meta-Analysis ; Systematic Review ; Journal Article
ZDB-ID	2091323-0
ISSN	1472-6823 ; 1472-6823
ISSN (online)	1472-6823
ISSN	1472-6823
DOI	10.1186/s12902-024-01545-0
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Vitamin D levels in idiopathic inflammatory myopathy patients: a meta-analysis.

Xiong, Anji / Zhou, Shifeng / Liu, Can / Hu, Ziyi / Xie, Chuanmei / Zheng, Xiaoli / Luo, Xiongyan

Postgraduate medicine

2024 Volume 136, Issue 2, Page(s) 141–149

Abstract: Purpose: This meta-analysis aimed to explore correlations between vitamin D and idiopathic inflammatory myopathy (IIM).: Methods: A comprehensive database search was conducted on 13 October 2020. Mean differences (MDs) and aggregated risk ratios (RR) ...

Abstract	Purpose: This meta-analysis aimed to explore correlations between vitamin D and idiopathic inflammatory myopathy (IIM). Methods: A comprehensive database search was conducted on 13 October 2020. Mean differences (MDs) and aggregated risk ratios (RR) with 95% confidence intervals (CIs) were used to determine the correlation between vitamin D deficiency (VDD) and IIM. Statistical analysis was performed with RevMan 5.4 and Stata15, statistical significance was set at Results: Search revealed five studies with 286 IIM patients and 480 healthy controls. Results with random-effects modeling indicated that serum vitamin D levels were significantly lower in IIM patients than in healthy controls (MD = -13.10 ng/mL; 95% CI: -16.51 to -9.68; Conclusion: This meta-analysis showed correlations between vitamin D level and IIM. The results indicated, VDD may be a risk factor for IIM, a determinant of immune dysregulation in IIM, or a consequence of IIM. Also, it implied further research to determine whether vitamin D supplementation is beneficial for patients with IIM.
MeSH term(s)	Humans ; Creatine Kinase/blood ; Myositis/blood ; Myositis/epidemiology ; Vitamin D/blood ; Vitamin D Deficiency/blood ; Vitamin D Deficiency/epidemiology ; Vitamin D Deficiency/complications
Chemical Substances	Creatine Kinase (EC 2.7.3.2) ; Vitamin D (1406-16-2)
Language	English
Publishing date	2024-03-04
Publishing country	England
Document type	Journal Article ; Meta-Analysis
ZDB-ID	410138-8
ISSN	1941-9260 ; 0032-5481
ISSN (online)	1941-9260
ISSN	0032-5481
DOI	10.1080/00325481.2024.2325335
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.407: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Cyclophosphamide: a Therapeutic Option for Amyotrophic Lateral Sclerosis.

Xiong, Anji / Xiang, Qilang / Cao, Yuzi / Shuai, Shiquan

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

2021

Language	English
Publishing date	2021-11-19
Publishing country	United States
Document type	Letter
ZDB-ID	2227405-4
ISSN	1557-1904 ; 1557-1890
ISSN (online)	1557-1904
ISSN	1557-1890
DOI	10.1007/s11481-021-10032-5
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Details ▾
- Full text online
- Order with fees

Article ; Online: Tacrolimus, cyclosporine, and grapefruit: Friends or foes?

Cao, Yuzi / Xiang, Qilang / Hu, Ziyi / Shuai, Shiquan / Xiong, Anji

Transplant immunology

2022 Volume 72, Page(s) 101584

MeSH term(s)	Citrus paradisi ; Cyclosporine/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Tacrolimus/therapeutic use
Chemical Substances	Immunosuppressive Agents ; Cyclosporine (83HN0GTJ6D) ; Tacrolimus (WM0HAQ4WNM)
Language	English
Publishing date	2022-03-20
Publishing country	Netherlands
Document type	Research Support, Non-U.S. Gov't ; Letter
ZDB-ID	1160846-8
ISSN	1878-5492 ; 0966-3274
ISSN (online)	1878-5492
ISSN	0966-3274
DOI	10.1016/j.trim.2022.101584
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3784: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Qualitative evaluation of connective tissue disease with cytomegalovirus infection: A meta-analysis of case reports.

Deng, Ruiting / Yuan, Gaodi / Ye, Yiman / Luo, Wenxuan / Zhong, Jiaxun / Wang, Haolan / Wei, Xin / Luo, Xiongyan / Xiong, Anji

Seminars in arthritis and rheumatism

2024 Volume 65, Page(s) 152396

Abstract: Background: The primary therapies for connective tissue disease include glucocorticoids and immunosuppressants. However, their prolonged usage can precipitate opportunistic infections, such as cytomegalovirus infection. When managing connective tissue ... ...

Abstract	Background: The primary therapies for connective tissue disease include glucocorticoids and immunosuppressants. However, their prolonged usage can precipitate opportunistic infections, such as cytomegalovirus infection. When managing connective tissue disease complicated by cytomegalovirus infection, judicious selection of treatment modalities is crucial. This involves assessing the necessity for antiviral therapy and contemplating the reduction or cessation of glucocorticoids and immunosuppressants. Objective: This investigation sought to methodically review existing literature regarding treating connective tissue disease patients with cytomegalovirus infection. Methods: On July 5, 2023, an exhaustive literature search was conducted. Data analysis utilized the Kruskal-Wallis test or one-way analysis of variance, supplemented by Bonferroni post hoc testing. Results: Our meta-analysis incorporated 88 studies encompassing 146 connective tissue disease patients with CMV infections. The results indicated that patients with connective tissue disease and cytomegalovirus disease benefitted more from antiviral therapy than those not receiving such treatment (P = 0.003, P < 0.005). Furthermore, the strategic reduction of glucocorticoids and/or immunosuppressants was beneficial (P = 0.037, P < 0.05). Poor clinical outcomes with glucocorticoid-immunosuppressant combination therapy compared to other treatment modalities. The findings also suggested that CMV infection patients fare better without Cyclosporine A than using it (P = 0.041, P < 0.05). Conclusion: Antiviral therapy is a viable treatment option in cases of connective tissue disease co-occurring with cytomegalovirus disease. Additionally, when connective tissue disease is stable, there is potential merit in reducing glucocorticoids and/or immunosuppressants, especially avoiding the combination of these drugs. For all cytomegalovirus infection patients, Cyclosporine A may be avoided wherever possible for selecting immunosuppressive agents if its use is not deemed essential in the treatment regimen.
MeSH term(s)	Humans ; Antiviral Agents/therapeutic use ; Cyclosporine/therapeutic use ; Cytomegalovirus Infections/complications ; Cytomegalovirus Infections/drug therapy ; Immunosuppressive Agents/therapeutic use ; Connective Tissue Diseases/complications ; Connective Tissue Diseases/drug therapy ; Glucocorticoids/therapeutic use
Chemical Substances	Antiviral Agents ; Cyclosporine (83HN0GTJ6D) ; Immunosuppressive Agents ; Glucocorticoids
Language	English
Publishing date	2024-02-05
Publishing country	United States
Document type	Meta-Analysis ; Case Reports ; Journal Article ; Review
ZDB-ID	120247-9
ISSN	1532-866X ; 0049-0172
ISSN (online)	1532-866X
ISSN	0049-0172
DOI	10.1016/j.semarthrit.2024.152396
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 790: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis.

Xiong, Anji / Luo, Wenxuan / Tang, Xiaoyu / Cao, Yuzi / Xiang, Qilang / Deng, Ruiting / Shuai, Shiquan

Seminars in arthritis and rheumatism

2023 Volume 63, Page(s) 152257

Abstract: Objective: Invasive fungal infections (IFIs) are life-threatening opportunistic infections in patients with connective tissue disease CTD) that cause significant morbidity and mortality. We attempted to determine the potential risk factors associated ... ...

Abstract	Objective: Invasive fungal infections (IFIs) are life-threatening opportunistic infections in patients with connective tissue disease CTD) that cause significant morbidity and mortality. We attempted to determine the potential risk factors associated with IFIs in CTD. Methods: We systematically searched PubMed, Embase, and the Cochrane Library databases for relevant articles published from the database inception to February 1, 2023. Results: Twenty-six studies were included in this systematic review and meta-analysis. Risk factors identified for IFIs were diabetes (odds ratio [OR], 1.62; 95% confidence interval [CI], 1.00 to 2.64), pulmonary diseases (OR 3.43; 95% CI 2.49 to 4.73), interstitial lung disease (ILD; OR, 4.06; 95% CI, 2.22 to 7.41), renal disease (OR, 4.41; 95% CI, 1.84 to 10.59), glucocorticoid (GC) use (OR, 4.15; 95% CI, 2.74 to 6.28), especially moderate to high-dose GC, azathioprine (AZA) use (OR, 1.50; 95% CI, 1.12 to 2.01), calcineurin inhibitor (CNI) use (OR, 2.49; 95% CI, 1.59 to 3.91), mycophenolate mofetil (MMF) use (OR, 2.83; 95% CI, 1.59 to 5.03), cyclophosphamide (CYC) use (OR, 3.35; 95% CI, 2.47 to 4.54), biologics use (OR, 3.43; 95% CI, 2.36 to 4.98), and lymphopenia (OR, 4.26; 95% CI, 2.08 to 8.73). Hydroxychloroquine (HCQ) use reduced risk of IFIs (OR, 0.67; 95% CI, 0.54 to 0.84). Furthermore, 17 of the 26 studies only reported risk factors for Pneumocystis jiroveci pneumonia (PJP) in patients with CTD. Pulmonary disease; ILD; and the use of GC, CNIs, CYC, methotrexate (MTX), MMF and biologics, and lymphopenia increased the risk of PJP, whereas the use of HCQ reduced its risk. Conclusion: Diabetes, pulmonary disease, ILD, renal disease, use of GC (especially at moderate to high dose) and immunosuppressive drugs, and lymphopenia were found to be associated with significant risk for IFIs (especially PJP) in patients with CTD. Furthermore, the use of HCQ may reduce the risk of IFIs in patients with CTD.
MeSH term(s)	Humans ; Connective Tissue Diseases/complications ; Cyclophosphamide/adverse effects ; Lung Diseases, Interstitial/etiology ; Mycophenolic Acid/therapeutic use ; Glucocorticoids/adverse effects ; Risk Factors ; Diabetes Mellitus/chemically induced ; Lymphopenia/chemically induced ; Lymphopenia/complications ; Biological Products ; Invasive Fungal Infections/drug therapy ; Invasive Fungal Infections/epidemiology ; Invasive Fungal Infections/etiology
Chemical Substances	Cyclophosphamide (8N3DW7272P) ; Mycophenolic Acid (HU9DX48N0T) ; Glucocorticoids ; Biological Products
Language	English
Publishing date	2023-08-22
Publishing country	United States
Document type	Meta-Analysis ; Systematic Review ; Journal Article ; Review
ZDB-ID	120247-9
ISSN	1532-866X ; 0049-0172
ISSN (online)	1532-866X
ISSN	0049-0172
DOI	10.1016/j.semarthrit.2023.152257
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 790: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito